TER
0,59% p.a.
Distributiebeleid
Accumulerend
Replicatie
Sampling
Fondsgrootte
8 m
Bedrijven
101
Overzicht
Verhandel deze ETF bij je broker
Beschrijving
The HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF seeks to track the Indxx Advanced Life Sciences & Smart Healthcare Thematic index. Der Indxx Advanced Life Sciences & Smart Healthcare Thematic index tracks global companies involved in sectors from robotics to bioinformatics.
Grafiek
Basis
Data
| Index | Indxx Advanced Life Sciences & Smart Healthcare Thematic |
| Investeringsfocus | Aandelen, Wereld, Gezondheidszorg |
| Fondsgrootte | EUR 8 m |
| Totale kostenratio (TER) | 0,59% p.a. |
| Replicatie | Fysiek (Geoptimaliseerde sampling) |
| Juridische structuur | ETF |
| Strategierisico | Langdurig |
| Duurzaamheid | No |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 29,21% |
| Oprichtingsdatum/Noteringsdatum | 4 april 2019 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ierland |
| Fondsaanbieder | HANetf |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | J.P. Morgan Administration Services (Ireland) Limited |
| Beleggingsadviseur | |
| Bewaarbank | J.P. Morgan SE - Dublin Branch |
| Revisiebedrijf | Ernst and Young |
| Einde belastingjaar | 31 maart |
| Vertegenwoordiger van Zwitserland | Waystone Fund Services (Switzeland) SA |
| Zwitserse uitbetalende instantie | Helvetische Bank AG |
| Duitsland | Onbekend |
| Zwitserland | ESTV Reporting |
| Oostenrijk | Belastingrapportagefonds |
| UK | UK-rapportage |
| Indextype | Totale rendementsindex |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | No |
| Tegenpartij die effecten uitleent |
Vergelijkbare ETF
In dit gedeelte vind je informatie over andere ETF met een vergelijkbare beleggingsfocus als de HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF
Vergelijkbare ETF via ETF zoeken
Vergelijkbare ETF via beleggingsgidsen
Wat vind je van ons ETF-profiel? Here you'll find our Questionnaire.
Bedrijven
Hieronder vind je informatie over de samenstelling van de HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF
Top 10 holdings
Weging van top 10-holdings
van 101
17,58%
| Hims & Hers Health | 2,51% |
| Telix Pharmaceuticals Ltd. | 2,00% |
| Natera | 1,92% |
| Peptidream, Inc. | 1,91% |
| Sarepta Therapeutics | 1,86% |
| PROCEPT BioRobotics | 1,53% |
| Glaukos | 1,48% |
| Boston Scientific Corp. | 1,48% |
| Twist Bioscience | 1,45% |
| Lantheus Holdings, Inc. | 1,44% |
Sectoren
| Gezondheidszorg | 91,94% |
| Essentiële consumptiegoederen | 1,61% |
| Consumer Discretionary | 1,53% |
| Anders | 4,93% |
Vanaf 28/06/2024
Prestaties
Rendementsoverzicht
| YTD | +9,51% |
| 1 maand | +0,36% |
| 3 maanden | +12,13% |
| 6 maanden | +7,68% |
| 1 jaar | +20,31% |
| 3 jaar | - |
| 5 jaar | - |
| Since inception | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
Maandelijks rendement in een heat map
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Volatiliteit 1 jaar | 29,21% |
| Volatiliteit 3 jaar | - |
| Volatiliteit 5 jaar | - |
| Rendement/Risico 1 jaar | 0,69 |
| Rendement/Risico 3 jaar | - |
| Rendement/Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | - |
| Maximaal waardedaling 3 jaar | - |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | - |
Voortschrijdende volatiliteit over 1 jaar
Beurs
Beursnoteringen
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Stuttgart Stock Exchange | EUR | W311 | - - | - - | - |
| Frankfurt Stock Exchange | EUR | - | W311 GY WELLEUIV | W311.DE WELLEURINAV=SOLA | RBC Europe Ltd |
| Xetra | EUR | W311 | WELLEUIV | WELLEURINAV=SOLA | RBC Europe Ltd |
Meer informatie
Andere ETF met vergelijkbare beleggingsfocus
| Naam fonds | Fondsgrootte in €m (AuM) | TER p.j. | Distributie | Replicatiemethode |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 1.048 | 0,40% p.a. | Accumulerend | Sampling |
| L&G Healthcare Breakthrough UCITS ETF USD Acc | 62 | 0,49% p.a. | Accumulerend | Volledige replicatie |
| L&G Pharma Breakthrough UCITS ETF | 17 | 0,49% p.a. | Accumulerend | Volledige replicatie |
| Harbor Health Care UCITS ETF Accumulating | 15 | 0,89% p.a. | Accumulerend | Volledige replicatie |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 6 | 0,35% p.a. | Accumulerend | Volledige replicatie |
Nieuwste artikelen
Veelgestelde vragen
What is the name of -?
The name of - is HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF.
What is the ticker of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF?
The primary ticker of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF is -.
What is the ISIN of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF?
The ISIN of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF is DE000A2PE7K4.
What are the costs of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF?
The total expense ratio (TER) of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF amounts to 0,59% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF paying dividends?
HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF?
The fund size of HANetf HAN-GINS Indxx Healthcare Innovation UCITS ETF is 8m Euro. See the following article for more information about the size of ETFs.
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing).